AGP Picks
View all

Furniture Press Releases
Provided by AGP

Furniture Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Furniture Press Releases.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 28, 2026

デノードのクラウドサービスであるアゴラ、マイクロソフト・マーケットプレイスで提供を開始し、エージェント型AIのユースケースを強化
May 28, 2026

デノードのクラウドサービスであるアゴラ、マイクロソフト・マーケットプレイスで提供を開始し、エージェント型AIのユースケースを強化

Indeterminate GlobeNewswire
Denodo의 클라우드 서비스 ‘Agora’, Microsoft Marketplace에 출시되며 에이전틱 AI 활용 지원
May 28, 2026

Denodo의 클라우드 서비스 ‘Agora’, Microsoft Marketplace에 출시되며 에이전틱 AI 활용 지원

Indeterminate GlobeNewswire
Agora, Denodo Cloud Service, kini tersedia di Microsoft Marketplace untuk Memacu Kes Penggunaan Agentic AI
May 28, 2026

Agora, Denodo Cloud Service, kini tersedia di Microsoft Marketplace untuk Memacu Kes Penggunaan Agentic AI

Indeterminate GlobeNewswire
Denodo 云服务 Agora 现已上线 Microsoft Marketplace，旨在赋能智能体 AI 应用场景
May 28, 2026

Denodo 云服务 Agora 现已上线 Microsoft Marketplace，旨在赋能智能体 AI 应用场景

Indeterminate GlobeNewswire
Denodo 雲端服務 Agora 現已登陸 Microsoft Marketplace，推動代理型 AI 應用場景
May 28, 2026

Denodo 雲端服務 Agora 現已登陸 Microsoft Marketplace，推動代理型 AI 應用場景

Indeterminate GlobeNewswire
LIFT Files NI 43-101 Technical Report on the Adina-Galinée Lithium Project, Quebec, Canada
May 28, 2026

LIFT Files NI 43-101 Technical Report on the Adina-Galinée Lithium Project, Quebec, Canada

Indeterminate GlobeNewswire
Theolytics’ Ongoing US Phase 1 OCTOPOD-IP Trial of THEO-260 in Ovarian Cancer to be Presented as a Trial in Progress at ASCO 2026
May 28, 2026

Theolytics’ Ongoing US Phase 1 OCTOPOD-IP Trial of THEO-260 in Ovarian Cancer to be Presented as a Trial in Progress at ASCO 2026

Indeterminate GlobeNewswire
Groundbreaking therapy for advanced heart failure: Outcomes of the BIOVAT-HF clinical trial published in NEJM
May 28, 2026

Groundbreaking therapy for advanced heart failure: Outcomes of the BIOVAT-HF clinical trial published in NEJM

Indeterminate GlobeNewswire
ARKAY Beverages Expands Its Zero-Proof Portfolio With BEYOND SPIRITS and BEYOND WHISKY Plant-Based
May 28, 2026

ARKAY Beverages Expands Its Zero-Proof Portfolio With BEYOND SPIRITS and BEYOND WHISKY Plant-Based

Indeterminate GlobeNewswire
Enterome receives U.S. FDA Orphan Drug Designation for EO2463 OncoMimics™ to treat “watch-and-wait” indolent non-Hodgkin lymphoma
May 28, 2026

Enterome receives U.S. FDA Orphan Drug Designation for EO2463 OncoMimics™ to treat “watch-and-wait” indolent non-Hodgkin lymphoma

Indeterminate GlobeNewswire
Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma
May 28, 2026

Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma

Indeterminate GlobeNewswire
Azerion publishes Interim Unaudited Financial Results Q1 2026
May 28, 2026

Azerion publishes Interim Unaudited Financial Results Q1 2026

Indeterminate GlobeNewswire
New late-breaking data reinforces IQIRVO®’s impact on ALP, fatigue and pruritus in PBC
May 28, 2026

New late-breaking data reinforces IQIRVO®’s impact on ALP, fatigue and pruritus in PBC

Indeterminate GlobeNewswire
De nouvelles données "late-breaking" renforcent l’impact d’IQIRVO® sur l’ALP, la fatigue et le prurit dans la CBP.
May 28, 2026

De nouvelles données "late-breaking" renforcent l’impact d’IQIRVO® sur l’ALP, la fatigue et le prurit dans la CBP.

Indeterminate GlobeNewswire
Basilea erhält weitere USD 13 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam
May 28, 2026

Basilea erhält weitere USD 13 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam

Indeterminate GlobeNewswire
Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
May 28, 2026

Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

Indeterminate GlobeNewswire
2026 World Intelligence Expo kicks off in north China's Tianjin
May 28, 2026

2026 World Intelligence Expo kicks off in north China's Tianjin

Indeterminate GlobeNewswire
VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement
May 28, 2026

VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement

Indeterminate GlobeNewswire
Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
May 28, 2026

Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease

Indeterminate GlobeNewswire
Communiqué de presse : Le venglustat de Sanofi a été accepté pour un examen prioritaire aux États-Unis afin de traiter la maladie de Gaucher de type 3  
May 28, 2026

Communiqué de presse : Le venglustat de Sanofi a été accepté pour un examen prioritaire aux États-Unis afin de traiter la maladie de Gaucher de type 3  

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Furniture Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.